These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26235977)

  • 21. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
    Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 3-year clinical outcomes between Resolute™ zotarolimus- and sirolimus-eluting stents for long coronary artery stenosis.
    Im E; Kim BK; Ko YG; Her AY; Choi HH; Shin DH; Kim JS; Choi D; Jang Y; Hong MK
    J Interv Cardiol; 2013 Aug; 26(4):378-83. PubMed ID: 23844852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
    Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
    Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis.
    Erglis A; Narbute I; Kumsars I; Jegere S; Mintale I; Zakke I; Strazdins U; Saltups A
    J Am Coll Cardiol; 2007 Aug; 50(6):491-7. PubMed ID: 17678730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial.
    Fajadet J; Wijns W; Laarman GJ; Kuck KH; Ormiston J; Münzel T; Popma JJ; Fitzgerald PJ; Bonan R; Kuntz RE;
    Minerva Cardioangiol; 2007 Feb; 55(1):1-18. PubMed ID: 17287679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
    Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions.
    Ruef J; Störger H; Schwarz F; Haase J
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):333-9. PubMed ID: 18288747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
    Mauri L; O'Malley AJ; Popma JJ; Moses JW; Leon MB; Holmes DR; Teirstein PS; Cutlip DE; Donahoe D; Kuntz RE
    Am J Cardiol; 2005 May; 95(10):1140-5. PubMed ID: 15877983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind, multicenter study of the polymer-based 17-beta estradiol-eluting stent for treatment of native coronary artery lesions: six-month results of the ETHOS I trial.
    Abizaid A; Chaves AJ; Leon MB; Hauptmann K; Mehran R; Lansky AJ; Baumbach W; Shankar H; Muller R; Feres F; Sousa AG; Sousa JE; Grube E
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):654-60. PubMed ID: 17932898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
    Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
    N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of stent treatment strategies in the long-term outcome of patients with long diffuse coronary lesions.
    Pan M; Suárez de Lezo J; Medina A; Romero M; González S; Segura J; Pavlovic D; Rodríguez M; Muñoz J; Ojeda S; Hernández E; Caballero E; Delgado A; Melián F
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):293-300. PubMed ID: 12594690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis.
    Kim YH; Lee JH; Roh JH; Ahn JM; Yoon SH; Park DW; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Seung KB; Shin WY; Lee NH; Lee BK; Lee SG; Nam CW; Yoon J; Yang JY; Hyon MS; Lee K; Jang JS; Kim HS; Park SW; Park SJ
    JACC Cardiovasc Interv; 2015 Apr; 8(4):550-60. PubMed ID: 25907082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions.
    Fonseca A; Costa Jde R; Abizaid A; Feres F; Abizaid AS; Costa R; Staico R; Mattos LA; Sousa AG; Grube E; Sousa JE
    J Invasive Cardiol; 2008 Jan; 20(1):21-7. PubMed ID: 18174614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year clinical outcome in an unselected patient population treated with the Genous™ endothelial progenitor cell capturing stent.
    Klomp M; Beijk MA; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):809-17. PubMed ID: 20853436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate and long-term results of a modified simultaneous kissing stenting for percutaneous coronary intervention of coronary artery bifurcation lesions.
    Isaaz K; Bayle S; Lamaud M; Robin C; Cerisier A; Mayaud N; Richard L; Sabry MH; Khamis H; Abd-Alaziz A; Da Costa A
    J Invasive Cardiol; 2013 Mar; 25(3):126-31. PubMed ID: 23468441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buddy wire technique for stent placement at non-aorto ostial coronary lesions.
    Cheema A; Hong T
    Int J Cardiol; 2007 Jun; 118(3):e75-80. PubMed ID: 17400315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.